Regulations.gov document
Exhibit-2 - Current and Resolved Drug Shortages and Discontinuations Reported to FDA…
Supporting & Related Material · FDA-2018-P-4549 · posted Nov 29, 2018
Key facts
| Document ID | FDA-2018-P-4549-0004 |
|---|---|
| Title | Exhibit-2 - Current and Resolved Drug Shortages and Discontinuations Reported to FDA: Reference for Discontinuation ofLamisil Tablets, 250 mgre: Citizen Petition from Unichem Pharmaceuticals (USA), Inc. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2018-P-4549 |
| Posted | Nov 29, 2018 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: